Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Migration of unmigrated content due to installation of a new plugin
TASKWhoDunnitObserved
Split cellsAG, CR, GB, JA, LA, SSAW
Seed platesAG, CR, GB, LA, SSAW
TransfectionAG, GB, LAAC, SS
FACS PrepAG, LACR
Imaging (FloCyto)BTAG, AW, CR, JX, LA

 

Practice Transfections:

Toggle Cloak
CONTROLS

Cloak
  1. +ve: single color transfection (eYFP, eBFP or mKate, as appropriate)
  2. +ve/+ve: tri-color control (eYFP, eBFP and mKate co-transfected: allows for comparison of color/intensity when imaging)
  3. -ve: perform protocol, excluding DNA, or with dummy DNA
  4. -ve/-ve: no actions performed on cells

Toggle Cloak
PRACTICE #1: Fluorescent protein under constitutive promoter

Cloak
11 complete 6/23: Seed cells 12 complete 6/24: Transfect hEF1a:eYFP (472 ng/uL) into HEK cells 13 complete 6/26 (4.30pm): Flow Cytometer
  • Determine optimal Lipofectamine LTX volume (24 well)
  • Determine transfection efficiency (quantitatively)

RESULT: Decent transfection efficiency (~60%). Move on to Practice #2.

Toggle Cloak
PRACTICE #2: Co-transfection (2 fluorescent proteins under constitutive promoter)

Cloak

ATTEMPT #1

36 complete 7/3: Seed cells 23 complete 7/4: Transfect hEF1a:eYFP (472 ng/uL) and hEF1a:tagBFP (1176 ng/uL) into HEK cells 24 complete 7/6 (1pm): Flow Cytometer

 

  • DNA Dilution: 10uL hEF1a:eYFP; 5uL hEF1a:tagBFP
  • (Y+B)x: add 1:1 (25uL hEF1a:eYFP/tagBFP-lipid complex)
Y1
  • hEF1a:eYFP
(Y+B)1
  • hEF1a:eYFP
  • hEF1a:tagBFP
////// ////// ////// -ve control
  • dummy DNA
  • with Lipofectamine
Y2
  • hEF1a:eYFP
(Y+B)2
  • hEF1a:eYFP
  • hEF1a:tagBFP
////// ////// ////// -ve control
  • dummy DNA
  • with Lipofectamine
B1
  • hEF1a:tagBFP
(Y+B)3
  • hEF1a:eYFP
  • hEF1a:tagBFP
////// ////// ////// -ve/-ve control
  • no DNA
  • no Lipofectamine
B2
  • hEF1a:tagBFP
(Y+B)4
  • hEF1a:eYFP
  • hEF1a:tagBFP
////// ////// ////// -ve/-ve control
  • no DNA
  • no Lipofectamine

RESULT: Extremely low transfection efficiency (<10%). Repeat to improve co-transfection results.

 

ATTEMPT #2

22 complete 7/9: Seed cells 37 complete 7/10: Transfect hEF1a:mKate (621 ng/uL) and hEF1a:eBFP (405 ng/uL) into HEK cells 38 incomplete complete 7/12 (1:30pm): Flow Cytometer

 

  • DNA Dilution: 8.1uL (10 uL) hEF1a:mKate; 12.3uL (15 uL) hEF1a:eBFP
  • (R+B)x: add 1:1 (25uL hEF1a:mKate/eBFP-lipid complex)
R1
  • hEF1a:mKate
(R+B)1
  • hEF1a:mKate
  • hEF1a:eBFP
//////////////////-ve control
  • dummy DNA
  • with Lipofectamine
R2
  • hEF1a:mKate
(R+B)2
  • hEF1a:mKate
  • hEF1a:eBFP
//////////////////-ve control
  • dummy DNA
  • with Lipofectamine
B1
  • hEF1a:eBFP
(R+B)3
  • hEF1a:mKate
  • hEF1a:eBFP
//////////////////-ve/-ve control
  • no DNA
  • no Lipofectamine
B2
  • hEF1a:eBFP
(R+B)4
  • hEF1a:mKate
  • hEF1a:eBFP
//////////////////-ve/-ve control
  • no DNA
  • no Lipofectamine

RESULT:  Efficiency ~20%

 

Toggle Cloak
PRACTICE #3: Fluorescent protein under inducible promoter (DOX ladder)

Cloak
14 complete 7/10: Seed cells 15 incomplete complete 7/11: Transfect TRE:mKate (431 ng/uL), hEF1a:rtTA (___ 169 ng/uL) and hEF1a:eYFP (1045 ng/uL - transfection marker) into HEK cells 16 incomplete complete 7/12: Add DOX 18 incomplete complete 7/13 (__pm1:30pm): Flow Cytometer

 

  • DNA Dilution: __uL 4.8uL hEF1a:eYFP; __uL 29.6uL hEF1a:rtTA; __uL 11.6uL TRE:mKate
  • Conc. of DOX: 1mg/uL
  • (D=x): add _2:_1:_2
    1. __uL 20uL hEF1a:eYFP-lipid complex
    2. __uL 10uL hEF1a:rtTA-lipid complex
    3. __uL 20uL TRE:mKate-lipid complex

 

+ve control
  • hEF1a:eYFP
+ve control
  • hEF1a:eYFP
-ve control
  • dummy DNA
  • with Lipofectamine
-ve control
  • dummy DNA
  • with Lipofectamine
-ve/-ve control
  • no DNA
  • no Lipofectamine
-ve/-ve control
  • no DNA
  • no Lipofectamine
////////////////////////////////////
(D=0)1
  • no DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
(D=0)2
  • no DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
D=0.21
  • 1mg
  • 0.2uM DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
D=12(*3)
  • 2mg
  • 1uM DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
D=1.3(*5)
  • 1.5uM 3mg DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
D=34(*10)
  • 4mg
  • 3uM DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
D=45(*2)
  • 5mg
  • 4uM DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
D=6(*4)
  • 6uM 6mg DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
D=7.5(*6)
  • 7mg
  • 7.5uM DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
D=108(*7)
  • 8mg
  • 10uM DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
D=179(*8)
  • 9mg
  • 17uM DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate
D=3010(*9)
  • 10mg
  • 30uM DOX
  • hEF1a:eYFP
  • hEF1a:rtTA
  • TRE:mKate

RESULTS: Efficiency >50%


toggleSUBGROUP-cloakPRACTICE #4**: Co-transfection (2 fluorescent proteins under constitutive & inducible promoters)

Cloak 29 incomplete 7/_: Seed cells 30 incomplete 7/_: Transfect hEF1a:eYFP, TRE:mKate and hEF1a:rtTA** into HEK cells 31 incomplete 7/_: Add DOX 32 incomplete 7/_ (__pm): Flow Cytometer

SPECIFIC PRACTICE EXPERIMENTS

Inducible and Constitutive Cascades